基于多层双氧化物 (LDH) 的纳米三脚架用于与新陈代谢平衡相关的高输入力动疗法
Kai Song1,2, Xueting Yang1,3, Yingying Ren2
1Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, P. R. China.
ACS applied bio materials
|December 11, 2024
概括
研究人员开发了一种新型的高氧化物纳米三脚,用于高动态疗法. 这种药物有效地产生反应性氧物种并破坏瘤代谢,为癌症治疗和成像提供了一个有希望的策略.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 多元素过渡金属化合物显示出生物医学应用的前景.
- 合成这些化合物通常需要具有挑战性的高温处理.
- 开发新型药物用于先进疗法,如高动态疗法至关重要.
研究的目的:
- 合成一种新型的高氧化物 (HEO) 纳米三脚体剂,用于高动态疗法.
- 调查该药物产生反应性氧物种 (ROS) 和破坏瘤代谢的能力.
- 评估该药物的磁共振成像 (MRI) 导向治疗潜力.
主要方法:
- 通过多层双氧化物 (LDH) 前体的拓变化制造HEO纳米三足剂.
- 通过结构性障碍调节的ROS发电效率的评估.
- 评估该药物对细胞内代谢平衡 (NADH/NAD+) 和NO类活性的影响.
- 在体外和体外实验治疗疗效和MRI指导.
主要成果:
- 成功合成了具有可调节障碍的HEO纳米三脚体剂.
- 通过结构性流来证明高效的ROS生成和调节.
- 破坏瘤细胞代谢,影响NADH/NAD+循环,并表现出NO类活性,导致亡.
- 在体外和体外模型中证实了该药物适用于MRI导向治疗的适用性.
结论:
- 开发的HEO纳米三脚是一种新且有效的高动态治疗剂.
- 这种药物通过诱导代谢失衡和亡,为癌症治疗提供了一个有希望的策略.
- 这些发现突出了开发具有成像能力的先进治疗剂的新方法.
相关概念视频
Lysosomal Hydrolases
3.6K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.6K
Modified-Release Drug Delivery Systems: Rate-Programmed I
175
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
175
Modified-Release Drug Delivery Systems: Stimuli-Activated
186
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
186


